ArticleRSC advances2025
Fluorescence sensing of glucose at nanomolar levels using an imprinted copolymer embedded with carbon quantum dots.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Carbon Quantum Dot-Based Sensors: Photochemical Principles and Multimodal Applications.Materials (Basel, Switzerland) · 2026Review
- Evolution of Biosensors and Current State-of-the-Art Applications in Diabetes Control.Biosensors · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monitoring glucose levels in intracellular fluid is important in healthcare, as it directly correlates with cell metabolism-related diseases. However, conventional methods typically require high-end equipment and can only be performed in laboratory settings. In this study, an imprinted copolymer composed of 3-aminopropyltriethoxysilane and tetraethyl orthosilicate, embedded with carbon quantum dots (CQDs), was developed for fluorescence-based glucose sensing. A facile preparation method yielded CQDs with sizes ranging from 0.7 to 5 nm and fluorescence emission at a wavelength of 435 nm. These CQDs were incorporated into a polymeric matrix in the presence of glucose, followed by a molecular imprinting process. The resulting polymeric particles exhibited a diameter of approximately 604 ± 15 nm and contained binding cavities that matched the spatial arrangement of hydroxyl groups on glucose. The fluorescence intensity of the CQDs was highly dependent on glucose adsorption. Leveraging these properties, the imprinted polymer exhibited successful glucose recognition in the intracellular fluid-mimicking solution, achieving a limit of detection of 29.4 nM. A good linear correlation (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.